Alphabet Completes Verily Separation, May Be Sold

Alphabet has spent the past two years decoupling its life‑sciences unit Verily so it can operate independently and be sold or spun off, a senior Google executive testified during the company’s federal antitrust trial. Heather Adkins said Verily's systems were moved from Google’s internal infrastructure onto Google Cloud and that its technical and operational separation was completed at the end of 2024 to support independent growth within Alphabet. The restructuring follows Alphabet’s $1 billion investment in Verily in September 2022 and has coincided with workforce reductions and the winding down of Verily’s medical‑devices program as the unit refocuses on real‑world evidence, healthcare data platforms, research and care. Company and reporting notes say the separation is meant to create capacity for strategic partnerships, global business development, acquisitions and a potential sale or spin‑off.